About The Genetics
The Genetics is a company based in Dietikon (Switzerland) founded in 1998. It operates as a B2B. The Genetics offers products and services including Small Molecule Wnt-Inhibitors, Small Molecule BACE Inhibitors, and Small Molecule Growth Inhibitors. The Genetics operates in a competitive market with competitors including AmerisourceBergen, Xantis Pharma, DCS Pharma, RUWAG and Globomedica, among others.
- Headquarter Dietikon, Switzerland
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of The Genetics
The Genetics offers a comprehensive portfolio of products and services, including Small Molecule Wnt-Inhibitors, Small Molecule BACE Inhibitors, and Small Molecule Growth Inhibitors.
Inhibitors targeting Wnt pathway for colorectal cancer treatment
Inhibitors reducing amyloid production for Alzheimer's disease
Inhibitors for controlling cellular growth in cancer
Funding Insights of The Genetics
Detailed funding history for The Genetics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by The Genetics
Investment portfolio details for The Genetics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - The Genetics
Detailed financials for The Genetics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
The Genetics Comparisons
Peer comparison for The Genetics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of The Genetics
The Genetics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, Xantis Pharma, DCS Pharma, RUWAG and Globomedica, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical distribution and supply chain services are provided globally.
|
|
| Locked | Locked | Locked |
Distributor of generic prescription and over-the-counter products
|
|
| Locked | Locked | Locked |
Pharmaceutical products are distributed by DCS Pharma in Switzerland.
|
|
| Locked | Locked | Locked |
Distributor of drugs
|
|
| Locked | Locked | Locked |
Diversified pharmaceutical drugs are distributed by Globomedica in Switzerland.
|
|
| Locked | Locked | Locked |
Serves as a diversified distributor in the healthcare sector.
|
Detailed competitors of The Genetics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on The Genetics
Complete news archive for The Genetics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about The Genetics
The Genetics was founded in 1998.
The Genetics is headquartered in Dietikon, Switzerland. It is registered at Dietikon, Zurich, Switzerland.
The GENETICS Company is a biopharmaceutical firm specializing in research, development, and commercialization of small molecule inhibitors. It targets therapies for colorectal cancer, Alzheimers disease, and other cancers by optimizing molecular pathways. Based in Paris, France, the company focuses on innovative treatments through scientific advancements and aims to provide solutions for patients via partnerships with healthcare entities. Their work involves identifying and testing compounds to address disease mechanisms.
The Genetics's top competitors include AmerisourceBergen, DCS Pharma and RUWAG.
The Genetics offers Small Molecule Wnt-Inhibitors, Small Molecule BACE Inhibitors, and Small Molecule Growth Inhibitors.